Verkazia™ (cyclosporine 0.1%) for the Treatment of Severe Vernal Keratoconjunctivitis is now Publicly Reimbursed in New Brunswick
SANTEN PHARM CO UNSP/ADR (SNPHY)
NASDAQ:AMEX Investor Relations:
santen.com/en/ir
Company Research
Source: Business Wire
TORONTO--(BUSINESS WIRE)--Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on ophthalmology, today announced that Verkazia (cyclosporine topical ophthalmic emulsion 0.1% w/v) eye drops for the treatment of severe vernal keratoconjunctivitis (VKC) is now publicly reimbursed in New Brunswick under the New Brunswick Drug Plans through Special Authorization Benefits for eligible patients who meet specific clinical criteria.Verkazia was approved for the treatment of severe vernal keratoconjunctivitis in children from 4 years of age through adolescence by Health Canada in 2018.1"Santen is pleased to see Verkazia reimbursed for patients living with severe VKC in New Brunswick, where patients meet the specific criteria under the Special Authorization Benefits,” said Carol Stiff, Head of Santen Canada Inc. “As a company dedicated to Ophthalmology, we aim to reduce the loss of social and economic opportunities fo
Show less
Read more
Impact Snapshot
Event Time:
SNPHY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNPHY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNPHY alerts
High impacting SANTEN PHARM CO UNSP/ADR news events
Weekly update
A roundup of the hottest topics